![](/img/cover-not-exists.png)
EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
Moerman, R. V., Arends, S., Meiners, P. M., Brouwer, E., Spijkervet, F. K. L., Kroese, F. G. M., Vissink, A., Bootsma, H.Volume:
73
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-203736
Date:
February, 2014
File:
PDF, 140 KB
english, 2014